HIGHLIGHTS
- What: In understanding AD, the ability to make targeted genetic modifications is of great significance to understanding its mechanisms and opens up possibilities for therapeutic remedies that are effective.
- Who: Yijin (Elsa) Wang from the Alice Smith School, KL, Malaysia have published the paper: The analysis of whether CRISPR-Cas9 is the way forward for Alzheimer’s disease treatment, in the : Proceedings of the 4th International Conference on Biological Engineering and Medical Science
- Future: In the future research should focus on optimising delivery approaches such as viral and non-viral_vectors that will enhance . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.